Physician profile
John B Davis
NPI 1639280282
$12,700.40
in general payments reported to CMS, 2019-2025
28 companies · $647 in 2025
The $647 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,210 · 2020: $118 · 2021: $5,601 · 2022: $4,429 · 2023: $384 · 2024: $311 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323 · Travel and Lodging: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.61 |
| Travel and Lodging | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $6,272.25 | 2019-2024 | Harmonic |
| Ethicon INC. | $2,525.00 | 2022 | |
| Intuitive Surgical, INC. | $1,612.70 | 2019-2023 | Da Vinci Surgical System |
| Organogenesis INC. | $523.89 | 2020-2025 | Cygnus Dual, Puraply, Simplimax |
| Medtronic, INC. | $434.00 | 2021-2025 | Maxtack, Venaseal, Sonicision |
| Regeneron Healthcare Solutions, INC. | $229.18 | 2023-2025 | Libtayo |
| Boston Scientific Corporation | $167.76 | 2019-2024 | Varithena Administration Pack, Cre Pro |
| Mauna Kea Technologies, INC. | $124.48 | 2023 | |
| Ethicon US, LLC | $112.44 | 2019-2022 | |
| Allergan, INC. | $106.84 | 2020-2022 | |
| Olympus America INC. | $79.91 | 2021-2024 | Visiglide |
| Smith+Nephew, INC. | $63.97 | 2023-2025 | Collagenase Santyl, Regranex |
| Trevena, INC. | $61.51 | 2022-2023 | Olinvyk |
| Apollo Endosurgery US INC | $55.56 | 2019 | |
| Kerecis Limited | $44.15 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $36.86 | 2021-2024 | Exparel |
| W. L. Gore & Associates, INC. | $36.29 | 2019-2021 | |
| Becton, Dickinson and Company | $31.26 | 2024 | Phasix Mesh |
| Portola Pharmaceuticals, LLC | $29.54 | 2019 | |
| Ferring Pharmaceuticals INC. | $23.33 | 2021 | |
| Davol INC. | $22.89 | 2022 | |
| Merck Sharp & Dohme LLC | $21.41 | 2020 | |
| Abbvie INC. | $19.78 | 2023 | Natrelle Saline-Filled Breast Implants |
| Bard Peripheral Vascular, INC. | $16.60 | 2021 | |
| Mallinckrodt Enterprises LLC | $14.28 | 2019 | |
| Senseonics, Incorporated | $14.00 | 2019 | |
| Braintree Laboratories, INC. | $11.92 | 2021 | |
| Phathom Pharmaceuticals, INC. | $8.60 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.